• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Voice-command health IT firm launches with $650,000 | Funding roundup

Voice-command health IT firm launches with $650,000 | Funding roundup

May 8, 2011 By MedCity News

Funding

A group of Cincinnati gastroenterologists have been joined by several business and technology partners to launch a health IT company that develops intraoperative voice-command software to document surgical procedures.

The company, eMerge Health Solutions, received $650,000 in investment commitments, including $250,000 from state-supported venture development group CincyTech.

eMerge is aiming to up that initial investment amount to $850,000, and the company plans to use the cash for operating capital and to further product development, according to a statement from CincyTech.

MedCity News logo

eMerge says its software will help doctors become more efficient and reduce documentation errors.

The company’s initial target market for its voice-command documentation software is self-contained gastroenterology units within ambulatory surgical centers and hospitals. eMerge estimates that target market to be valued at $250 million to $300 million, according to the statement.

eMerge has installed its system in four locations — three ambulatory surgery centers and Cincinnati’s Jewish Hospital.

Last month, the company hired a CEO, Alex Vidas, who has a background in software engineering and previously worked with imaging firm Pentax Medical, according to the statement.

“We will be offering a first-of-its-kind-product, the ability to document during a procedure using voice command and control,” Vidas said. “This allows the clinician to gain productivity benefits without taking focus away from the patient’s care.”

Here’s a roundup of the latest dealflow and investment news:

  • DexCom aims to raise $70 million with stock sale
    DexCom Inc. (NSDQ:DXCM), announced the sale of 4.7 million shares of its common stock. The last reported sale price of our common stock as reported by the Nasdaq Global Market on May 6, 2011 was $15.01 per share. The company expects to use the net proceeds from the sale of the shares for working capital and general corporate purposes. Closing of the offering is expected to occur on or about May 10. In addition, the company granted the transaction’s underwriters a 30-day option to purchase up to an additional 705,000 shares of common stock to cover over-allotments, if any.
    Read more
  • InspireMD goes public on OTC market
    InspireMD Inc. (OTC:NSPR) , the developer of the MGuard mesh protective stent system, announced today that it has been approved by FINRA to have its stock quoted on the Over-the-Counter Bulletin Board (OTCBB) under the symbol "NSPR". In addition, on March 31, InspireMD concluded a $9.7 million PIPE offering in which (i) it raised approximately $9.0 million of cash and (ii) approximately $0.7 million worth of debentures were converted.
    Read more
  • Connecticut Innovations leads $1 million round for Innovatient Solutions Inc.
    Connecticut Innovations, the state’s quasi-public authority responsible for technology investing and innovation development, today announced that it has made an investment of $500,000 in Innovatient Solutions Inc. of Farmington, Conn., through its Seed Investment Fund. CI led the investment round of $1 million, which also involved company founders and angel investors. Innovatient is developing a patient-centered information system aimed at improving communications between hospital care providers and patients, thus enhancing clinical outcomes and patient satisfaction.
    Read more
  • Miromatrix identifies first product, seeks $5 million
    Sometimes amazing feats of scientific research get all the attention, but the actual process of creating a company from that research and developing a product is rarely that glitzy. Take the case of Miromatrix Medical Inc., the Eden Prairie, Minn. company trying to become a viable business by commercializing the stunning science of Dr. Doris Taylor, director for the University of Minnesota’s Center for Cardiovascular Repair. In the lab, Taylor’s research team drained the heart of a dead rat of cellular material until only the extracellular matrix or tissue scaffold remained. Then, researchers filled the vacuum of the empty heart shell with cells from new born rats and managed to create a beating animal heart, an extraordinary medical breakthrough, writes MedCity News.
    Read more
  • Elekta raises $200 million through private placement
    Elekta (STO:EKTAB) has strengthened its long term loan financing by entering into a private placement agreement with U.S. institutional investors. The transaction amount is $200 million with tenors between seven and twelve years. Bank of America Merrill Lynch has been the placement agent in the transaction.
    Read more
  • Cardiac Network announces reverse stock split
    Cardiac Network Inc. (OTC:CNWI.PK) announced that the it will effect a 1-for-750 reverse stock split. The split took effect on the opening of business and trading on May 6. On the effective date, the company’s trading symbol will be changed from "CNWI" to "CNWID" for approximately 20 business days, after which it will revert to CNWI. Upon the effectiveness of the split and as of the effective date, there will be approximately 109,345 shares of the company’s common stock issued and outstanding.
    Read more
  • Awarepoint drums up $14 million
    Awarepoint closed a $14 million debt-based financing, according to a pair of recent regulatory filings (here and here), Xconomy reported. Awarepoint last month acquired Charlotte, N.C.-based Patient Care Technology Systems. The company also named a new CEO, Jay Deady, and raised $9 million about six months ago. Awarepoint has previously raised capital from Silicon Valley Bank, Avalon Ventures, Cardinal Partners, JAFCO Ventures, and Venrock, according to the publication. The company makes real-time location system (RTLS) solutions for hospitals.
    Read more

Filed Under: News Well Tagged With: Awarepoint Corp., Cardiac Network Inc., Dexcom, eMerge Health Solutions, InspireMD, Miromatrix Medical Inc., Venture Capital/Private Equity

More recent news

  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford
  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy